Alice Labianca
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 6
- Cutaneous Melanoma Detection and Management 2
- Cancer Immunotherapy and Biomarkers 2
- Colorectal Cancer Treatments and Studies 2
- Cancer Cells and Metastasis 1
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Alice Indini (3 shared papers)Bożena Cybulska-Stopa (2 shared papers)Mario Mandalà (2 shared papers)Paweł Rogala (2 shared papers)Paweł Teterycz (2 shared papers)Piotr Lukasz Rutkowski (2 shared papers)Jacopo Pigozzo (1 shared paper)Giovanni Randon (1 shared paper)
- Journals
- European Journal of Cancer (2 papers)Cancers (2 papers)Annals of Oncology (2 papers)Journal of Thoracic Oncology (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- ItalyPolandUnited States
In The Last Decade
Alice Labianca
10 papers receiving 275 citations
Peers
Comparison fields: 5 of 37
- Oncology 186
- Pulmonary and Respiratory Medicine 63
- Cancer Research 17
- Immunology 25
- Internal Medicine 3
Countries citing papers authored by Alice Labianca
This map shows the geographic impact of Alice Labianca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Labianca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Labianca more than expected).
Fields of papers citing papers by Alice Labianca
This network shows the impact of papers produced by Alice Labianca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Labianca. The network helps show where Alice Labianca may publish in the future.
Co-authors
The 25 scholars most cited alongside Alice Labianca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 122 | |
| 2 | 2021 | 45 | |
| 3 | 2020 | 43 | |
| 4 | 2020 | 30 | |
| 5 | 2020 | 11 | |
| 6 | 2020 | 8 | |
| 7 | 2020 | 8 | |
| 8 | 2020 | 6 | |
| 9 | 2021 | 4 | |
| 10 | 2023 | 3 |
About Alice Labianca
Alice Labianca is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Internal Medicine, Emergency Medical Services and Cancer Research, having authored 10 papers that have together received 280 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), Cutaneous Melanoma Detection and Management (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Venous Thromboembolism Diagnosis and Management (1 paper), Cancer Genomics and Diagnostics (1 paper), Cancer Cells and Metastasis (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (186 citations), Pulmonary and Respiratory Medicine (63 citations), Cancer Research (17 citations), Immunology (25 citations) and Internal Medicine (3 citations). Alice Labianca has collaborated with scholars based in Italy, Poland and United States. Frequent co-authors include Alice Indini, Bożena Cybulska-Stopa, Mario Mandalà, Paweł Rogala, Paweł Teterycz, Piotr Lukasz Rutkowski, Jacopo Pigozzo, Giovanni Randon, Sławomir Falkowski and Lorenza Di Guardo. Their work appears in journals such as European Journal of Cancer, Cancers, Annals of Oncology, Journal of Thoracic Oncology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.